Substituted chroman compounds as calcium sensing receptor modulators
US-2015368222-A1 · Dec 24, 2015 · US
for electrolyte homeostasis
for electrolyte homeostasis · Cooperative Patent Classification (CPC)
Agriculture, food, personal care, health, and life sciences.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | A61P3/12 |
| Official title | for electrolyte homeostasis |
| Display label | for electrolyte homeostasis |
| Total patents | 488 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 69 |
| 2016 | 67 |
| 2017 | 64 |
| 2018 | 58 |
| 2019 | 49 |
| 2020 | 35 |
| 2021 | 39 |
| 2022 | 28 |
| 2023 | 28 |
| 2024 | 28 |
| 2025 | 21 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Nucleoside phosphoramidates
US-9206217-B2 · Dec 8, 2015 · US
Heteroaromatic compounds and their use as dopamine d1 ligands
US-2015344474-A1 · Dec 3, 2015 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2015336892-A1 · Nov 26, 2015 · US
Fluorene compound and pharmaceutical use thereof
US-2015329491-A1 · Nov 19, 2015 · US
Amide dendrimer compositions
US-2015321996-A1 · Nov 12, 2015 · US
Substituted N-phenethyltriazoloneacetamides and use thereof
US-9180120-B2 · Nov 10, 2015 · US
Solid pharmaceutical composition
US-9173849-B2 · Nov 3, 2015 · US
Substituted chroman compounds as calcium sensing receptor modulators
US-9163001-B2 · Oct 20, 2015 · US
Heterocyclic compounds and uses thereof
US-2015290207-A1 · Oct 15, 2015 · US
Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
US-9156834-B2 · Oct 13, 2015 · US
Activin-actrii antagonists and uses for treating bone and other disorders
US-2015283209-A1 · Oct 8, 2015 · US
Human LCAT Antigen Binding Proteins and Their Use in Therapy
US-2015284471-A1 · Oct 8, 2015 · US
Mineralocorticoid receptor antagonists
US-2015284376-A1 · Oct 8, 2015 · US
Heteroaromatic compounds and their use as dopamine D1 ligands
US-9139561-B2 · Sep 22, 2015 · US
Clay Mineral for Reducing Inorganic Phosphates, In Particular In Renal Replacement Therapy
US-2015258138-A1 · Sep 17, 2015 · US
Heteroaromatic compounds and their use as dopamine D1 ligands
US-9133190-B2 · Sep 15, 2015 · US
Diarylalkanes as potent inhibitors of binuclear enzymes
US-9126913-B2 · Sep 8, 2015 · US
Pharmaceutical composition and administrations thereof
US-2015246031-A1 · Sep 3, 2015 · US
Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds
US-9120797-B2 · Sep 1, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC A61P3/12?
- CPC A61P3/12 is the Cooperative Patent Classification code for “for electrolyte homeostasis.”
- How many patents are filed under CPC A61P3/12 (for electrolyte homeostasis)?
- Our database includes 488 publications tagged with this CPC code.
- Is patent activity under CPC A61P3/12 growing?
- Publication counts under this code: 28 in 2024 vs 21 in 2025 (latest complete years).